EUVIMEDEUVIMED entdecken
Crossref

Biogenic-Extract-Modified Sol-Gel Synthesis of ZnO Nanoparticles: Dual Antimicrobial Action and HaCaT Cell Compatibility Towards Potential Wound Healing Applications

Fatmanur Kocaman Kabil, Enes Furkan Sakar, Ayse Sevval Martin, Basak Dalbayrak, Elif Damla Arisan, Derya Berikten, Zehra Banu Bahsi

Biomedical Materials & Devices · 11.11.2026

DOI: 10.1007/s44174-026-00775-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials & Devices, online erschienen am 11.11.2026. Verfasst von Fatmanur Kocaman Kabil und 6 weiteren Autor:innen. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Scientific Research Projects Unit (BAP) of Gebze Technical University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zinc oxide nanoparticles (ZnO NPs) are promising antimicrobial components for advanced wound dressings, yet their defect chemistry, cytocompatibility and biosafety remain insufficiently correlated under biologically relevant conditions. In this study, ZnO NPs were biosynthesized via a sol–gel-like approach using extracellular metabolites of the thermophilic fungus Rhizomucor pusillus (R. pusillus) and subsequently calcined at 350°C (ZnO350) and 450°C (ZnO450). Analyses of XRD, FESEM/EDS, Raman, EPR, DLS, zeta potential and UV–Vis–NIR revealed wurtzite ZnO with temperature-dependent structural and surface properties: ZnO450 exhibited smaller coherent crystallite size, higher dislocation density, increased oxygen vacancy-related signatures, a narrowed band gap and a shift of zeta potential from negative (− 19.62 mV) to slightly positive (+ 5.12 mV). HaCaT assays showed dose-dependent cytotoxicity, with both ZnO350 and ZnO450 maintaining >95% cell viability at 5–10 µg/mL and pronounced toxicity only at ≥50 µg/mL, defining a safe concentration window for skin contact. Antimicrobial testing against a broad panel of Gram-positive, Gram-negative and fungal strains, including antibiotic-resistant pathogens, demonstrated notable but strain-dependent activity: ZnO350 reached its lowest MIC (10 µg/mL) only for Staphylococcus aureus ( S. aureus ), whereas ZnO450 achieved MIC values of 10 µg/mL and below for S. aureus , Methicillin-resistant Staphylococcus aureus (MRSA) and Aspergillus niger ( A. niger) , while all other microorganisms required higher concentrations. MBC data further showed a 10 µg/mL bactericidal value exclusively for ZnO450 against S. aureus . These results indicate that calcination-controlled defect engineering modulates antimicrobial selectivity without compromising keratinocyte viability, highlighting biosynthesized ZnO350 and ZnO450 as promising, sustainable candidates for incorporation into multifunctional wound-dressing systems. Graphical Abstract

Förderung

  • Scientific Research Projects Unit (BAP) of Gebze Technical University

Zitieren

APA

Kabil, F. K., Sakar, E. F., Martin, A. S., Dalbayrak, B., Arisan, E. D., Berikten, D., & Bahsi, Z. B. (2026). Biogenic-Extract-Modified Sol-Gel Synthesis of ZnO Nanoparticles: Dual Antimicrobial Action and HaCaT Cell Compatibility Towards Potential Wound Healing Applications. Biomedical Materials & Devices. https://doi.org/10.1007/s44174-026-00775-1

Vancouver

Kabil FK, Sakar EF, Martin AS, Dalbayrak B, Arisan ED, Berikten D, et al. Biogenic-Extract-Modified Sol-Gel Synthesis of ZnO Nanoparticles: Dual Antimicrobial Action and HaCaT Cell Compatibility Towards Potential Wound Healing Applications. Biomedical Materials & Devices. 2026. doi:10.1007/s44174-026-00775-1

BibTeX
@article{Kabil2026,
  author = {Kabil, Fatmanur Kocaman and Sakar, Enes Furkan and Martin, Ayse Sevval and Dalbayrak, Basak and Arisan, Elif Damla and Berikten, Derya and Bahsi, Zehra Banu},
  title = {Biogenic-Extract-Modified Sol-Gel Synthesis of ZnO Nanoparticles: Dual Antimicrobial Action and HaCaT Cell Compatibility Towards Potential Wound Healing Applications},
  journal = {Biomedical Materials & Devices},
  year = {2026},
  doi = {10.1007/s44174-026-00775-1}
}
Kostenlos starten →